Vijaya Diagnostic Centre Limited has announced a key leadership change with the resignation of its Company Secretary & Compliance Officer. The diagnostic services company informed stock exchanges about this corporate development through a regulatory filing.

Leadership Transition Details

Mr. Hansraj Singh has resigned from his position as Company Secretary & Compliance Officer of the company, with his last working day scheduled for March 16, 2026. The resignation was submitted due to personal reasons, as disclosed in the company's official communication to the stock exchanges.

Resignation Communication

In his resignation email addressed to the management, Singh explained his decision to step down from his role. He cited his intention to pursue new professional opportunities that align with his long-term career growth and development goals. Singh expressed gratitude for the opportunities, support, and trust extended to him by the management and team during his tenure with the company.

The outgoing Company Secretary emphasized his commitment to ensuring a smooth and seamless transition process. He assured the management that he would dedicate his efforts to effectively hand over his responsibilities before his departure.

Company's Response

Vijaya Diagnostic Centre has acknowledged Singh's resignation and placed on record its deep appreciation for the services rendered by him. The company recognized his contributions during his time as Company Secretary & Compliance Officer. The management expressed gratitude for his dedicated service and the valuable relationships he built within the organization.

Regulatory Compliance

The company has fulfilled its disclosure obligations under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notification was submitted to both the National Stock Exchange of India Limited and BSE Limited, ensuring compliance with regulatory requirements for such corporate announcements.

The resignation represents a planned leadership transition, with Singh expressing his best wishes for the company's continued success and growth in the years ahead.

US-based investment firm Wasatch Advisors LP has reduced its shareholding in Vijaya Diagnostic Centre Ltd through an open market transaction, as disclosed under SEBI's Substantial Acquisition of Shares and Takeovers (SAST) Regulations. The disclosure was filed with the National Stock Exchange of India and BSE Limited on February 20, 2026.

Transaction Details

The investment firm sold 23,608 shares of Vijaya Diagnostic Centre Ltd on February 19, 2026, through open market sale. This transaction represents a reduction of 0.023% in the firm's shareholding percentage.

Shareholding Position

Following the share disposal, Wasatch Advisors LP's shareholding in Vijaya Diagnostic Centre Ltd has been adjusted as follows:

Company Information

Vijaya Diagnostic Centre Ltd maintains its equity share capital structure with the following parameters:

Regulatory Compliance

The disclosure was made under Regulation 29(2) of SEBI (SAST) Regulations, 2011, which mandates reporting of substantial changes in shareholding. Dan Thurber, VP and General Counsel of Wasatch Advisors LP, signed the disclosure document on behalf of the firm. Wasatch Advisors LP is not part of the promoter or promoter group of Vijaya Diagnostic Centre Ltd.

The shares of Vijaya Diagnostic Centre Ltd are listed on both BSE and NSE, providing liquidity for such institutional transactions. The firm's reduced but continued shareholding indicates ongoing investment interest in the diagnostic services company.